Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy
CRISPR, the disruptor : Nature News & Comment
New CRISPR genome-editing system can target disease-causing genetic variations – Harvard Gazette
CRISPR gene editing - Wikipedia
Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL
Kill Switch for CRISPR Could Make Gene Editing Safer - Scientific American
Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
CRISPR-Cas 9 corrects genetic defects in mice
Nature Medicine》基因编辑工具增加致癌隐患- 生物通
Four U.S. CRISPR Trials Editing Human DNA to Research New Treatments | Science | Smithsonian Magazine
Focus on CRISPR tools and therapies | Nature Biotechnology
CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies - Scientific American
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
First Trial of CRISPR-Edited T cells in Lung Cancer: Trends in Molecular Medicine
Nature Medicine on Twitter: "Two studies find that #AAV-mediated #CRISPR/ Cas9 therapy extends life span and ameliorates disease-related phenotypes in a mouse model of #progeria. https://t.co/2LfOogSXLX and https://t.co/y5KjuD5Yjb… https://t.co/RMaa25wQoI"
First CRISPR editing trial results assuage safety concerns
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine
CRISPR-engineered T cells in patients with refractory cancer | Science
PDF) The CRISPR tool kit for genome editing and beyond
CRISPR algorithm predicts how well gene editing will work - Scope
CRISPR-Cas9 babies likely to die earlier, Berkeley study says | Science| In-depth reporting on science and technology | DW | 03.06.2019
Untangling the CRISPR cancer scare
CRISPR, the disruptor : Nature News & Comment
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
